Saptak Chem And Business Fund Raise

Financial Results

Saptak Chem And Business Q2 FY27 Results: Net Profit ₹0 Cr

Saptak Chem And Business Ltd reported net profit of ₹0 Cr for Q2 FY27.

Key figure

Net profit ₹0 Cr

Board Meeting Date

Saptak Chem And Business Board Meeting Date

Saptak Chem and Business Limited scheduled a board meeting for October 24, 2026, to approve the unaudited financial results for the quarter ended September 30, 2026.

Other Announcement

Saptak Chem And Business Other Announcement

The company filed the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming dematerialization details for the period ended September 30, 2026.

Annual General Meeting

Saptak Chem And Business Annual General Meeting

Saptak Chem and Business Limited held its 47th Annual General Meeting on August 29, 2026, via video conferencing. Shareholders transacted ordinary and special business items during the meeting.

Annual General Meeting

Saptak Chem And Business Annual General Meeting

Saptak Chem and Business Limited issued a corrigendum to its 47th AGM notice, rescheduling the meeting to August 29, 2026, and updating director appointment dates.

Annual Report

Saptak Chem And Business Annual Report

Saptak Chem and Business Limited has submitted its 47th Annual Report for the financial year 2025-26 to the BSE. The report is now available for shareholder reference.

Fund RaiseSudarshan Pharma Industries Ltd SUDARSHANAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Fund RaiseFlywings Simulator Training Centre Ltd FWSTCAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Fund RaiseKanel Industries Ltd KANELOILAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Fund RaiseSudarshan Pharma Industries Ltd SUDARSHANAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

Fund RaiseGAIL (India) Ltd GAILAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Fund RaiseGujarat Inject (Kerala) Ltd 524238Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr